A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...
1d
Vietnam Investment Review on MSNLion TCR s Liocyx M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV Related Hepatocellular CarcinomaOn 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...
In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve ...
Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...
Cancer cases in Jammu and Kashmir have increased by 50 percent at Paras Health Srinagar from September 2023 to January 2025, ...
Cancer remains a major health challenge in India, ranking as the third leading cause of death after infectious and ...
The lack of NHS funded testing for this type of cancer in Scotland means patients are denied targeted treatments unless they ...
Unlike the other more well-known type of liver cancer, hepatocellular carcinoma ... make sure that people who come after me ...
Imvax is targeting the same form of brain cancer that claimed the lives of former Phillies pitcher Tug McGraw and catcher ...
A multicenter prospective study to evaluate the efficacy of resection for initially unresectable hepatocellular carcinoma after atezolizumab combined with bevacizumab (the RACB study): Short-term ...
Upon admission, further examinations confirmed a diagnosis of hepatocellular carcinoma, which was specifically moderately differentiated (Stage IVA, T3N1M0). On June 27, 2023, the patient underwent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results